Wall Street’s Key Stock Analysts Research Report, All Buys
#stocks #bullish #buys #analysts #research #WallStreet
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy if you can manage the risk.
These are all Buys if you can manage the risk.
Below are our Buys for Friday, 29 January, as follows:
Abbott Laboratories (NYSE:ABT) was raised from Neutral to Buy with a 140 price target at BTIG Research. The Wall Street consensus target is 125.94.
American Express Co. (NYSE:AXP) was raised to Buy from Hold at DZ Bank, which has a 130 price objective. The consensus objective for the credit card giant is 130.76.
Exact Sciences Corp. (NASDAQ:EXAS) was started at Truist Securities with a Buy rating and a 226 target price. The consensus target is 160.80.
Invesco Ltd. (NYSE:IVZ) was upgraded at UBS from Neutral to Buy with a 24 price objective. That compares with the consensus objective of 22.04.
STMicroelectronics N.V. (NYSE:STM) was reiterated at Buy by Craig Hallum and saw its price target raised to 48 from 46. The consensus target is $41.64
Have a healthy weekend, Keep the Faith!
Palantir Stock (PLTR): BUY Rating, $250 Price Target — The 40% Dislocation
Palantir is down ~40% in 2026 even as Q1 revenue grew 85% and management guided FY2026 to $7.66B. Shayne Heffernan issues a BUY on PLTR with a $250 price target — full breakdown of the business, customers, five-year revenue, every major Wall Street bank target and the corporate outlook.
Boeing and Qatar Airways $BA Update
Elon Musk’s Latest Move Buy $TSLA
Investors should be watching Saudi Arabia
Every story, signed and delivered.
Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.